Maybe if I start from the beginning, I can make sense of what people mean when they call Finland “the happiest country in the ...

The strategy for treating multiple sclerosis (MS) is shifting from “preventing relapses” toward blocking disease progression ...

ViGenCell announced on Wednesday that it has recruited two executives to oversee business development and GMP operations to ...

Last year, Korea’s national health insurance system recorded a surplus of 499.6 billion won ($350.8 million) in its ...

Concerns were raised that the range of medications available for treating severe obesity among children and adolescents ...

Dong-A ST announced on Wednesday that Health Canada has granted marketing authorization for Imuldosa (ingredient: ustekinumab ...

The recent recognition of Korea’s Ministry of Food and Drug Safety (MFDS) as an official reference body in the medical products sector by the United Arab Emirates (UAE) was known to have been influenc ...

SAN FRANCISCO, Calif. – By Hong Sook / Korea Biomedical Review correspondent -- Samjin Pharmaceutical, long known for its ...

The Korean treatment landscape for ovarian cancer is poised for a significant shift as the first antibody-drug conjugate (ADC ...

Daiichi Sankyo Korea said Wednesday that its targeted therapy for acute myeloid leukemia (AML), Vanflyta (quizartinib), has ...

Boryung Consumer Healthcare announced on Wednesday that it held shareholders' and board of directors' meetings, appointing ...

Hanmi Pharmaceutical is accelerating its global expansion around efpeglenatide, Korea’s first independently developed ...